Home LiteratureArticle Details
PMID: 17420320 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Relation of diabetes to mild cognitive impairment.

Archives of neurology ·Vol. 64 ·No. 4 ·2007-04-00 ·Pages 570-5

Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R

Abstract

Type 2 diabetes mellitus is an important risk factor for Alzheimer disease and is more prevalent in elderly minority persons compared with non-Hispanic white persons. To determine whether diabetes is related to a higher risk of mild cognitive impairment (MCI), a transitional stage between normal cognition and Alzheimer disease, in a multiethnic cohort with a high prevalence of diabetes. Longitudinal cohort study. Northern Manhattan in New York, NY. We studied persons without prevalent MCI or dementia at baseline and with at least 1 follow-up interval. Of 1772 participants with a complete neuropsychological evaluation, 339 (19.1%) were excluded because of prevalent dementia, 304 were excluded because of prevalent MCI (17.2%), and 211 were excluded because of loss to follow-up (11.9%), resulting in a final sample of 918 participants for longitudinal analyses. We related diabetes defined by self-report to incident all-cause MCI, amnestic MCI, and nonamnestic MCI. We conducted multivariate analyses with proportional hazards regression adjusting for age, sex, years of education, ethnic group, apolipoprotein E (APOE) epsilon4 allele, hypertension, low-density lipoprotein level, current smoking, heart disease, and stroke. A total of 334 persons had incident MCI, 160 (47.9%) had amnestic MCI, and 174 (52.1%) had nonamnestic MCI. Diabetes was related to a significantly higher risk of all-cause MCI and amnestic MCI after adjustment for all covariates. Diabetes was also related to a higher risk of nonamnestic MCI, but this association was appreciably attenuated after adjustment for socioeconomic variables and vascular risk factors. The risk of MCI attributable to diabetes was 8.8% for the whole sample and was higher for African American persons (8.4%) and Hispanic persons (11.0%) compared with non-Hispanic white persons (4.6%), reflecting the higher prevalence of diabetes in minority populations in the United States. Diabetes is related to a higher risk of amnestic MCI in a population with a high prevalence of this disorder.

MeSH Terms
African Americans/statistics & numerical data Aged Aged, 80 and over Analysis of Variance Apolipoproteins E/genetics Cognition Disorders/epidemiology,etiology,psychology Cohort Studies Diabetes Mellitus, Type 2/complications,ethnology,genetics Female Follow-Up Studies Genotype Hispanic or Latino/statistics & numerical data Humans Male Middle Aged Neuropsychological Tests New York/epidemiology Prevalence Risk Factors Whites/statistics & numerical data
Chemicals
Apolipoproteins E
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Luchsinger José A
Department of Medicine, Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA. jal94@columbia.edu
Reitz Christiane
Patel Bindu
Tang Ming-Xin
Manly Jennifer J
Mayeux Richard
Article Info
Journal
Archives of neurology
Abbr.
Arch Neurol
ISSN
0003-9942
Published
2007-04-00
Pages
570-5
Language
English
Region
United States
NLM ID
0372436
Subset
IM
Grants
NIA NIH HHS · 1K08AG20856-01 · United States
NIA NIH HHS · AG07232 · United States
NIA NIH HHS · AG07702 · United States
NCRR NIH HHS · RR00645 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com